Dynamic pyrolytic reaction mechanisms, pathways, and products of medical masks and infusion tubes.

Given the COVID-19 epidemic, the quantity of hazardous medical wastes has risen unprecedentedly. This study characterized and verified the pyrolysis mechanisms and volatiles products of medical mask belts (MB), mask faces (MF), and infusion tubes (IT) via thermogravimetric, infrared spectroscopy, thermogravimetric-Fourier transform infrared spectroscopy, and pyrolysis-gas chromatography/mass spectrometry analyses. Iso-conversional methods were employed to estimate activation energy, while the best-fit artificial neural network was adopted for the multi-objective optimization. MB and MF started their thermal weight losses at 375.8 °C and 414.7 °C, respectively, while IT started to degrade at 227.3 °C. The average activation energies were estimated at 171.77, 232.79, 105.14, and 205.76 kJ/mol for MB, MF, and the first and second IT stages, respectively. Nucleation growth for MF and MB and geometrical contraction for IT best described the pyrolysis behaviors. Their main gaseous products were classified, with a further proposal of their initial cracking mechanisms and secondary reaction pathways.

Antimicrobial and Anticancer Application of Silver(I) Dipeptide Complexes.

Three silver(I) dipeptide complexes [Ag(GlyGly)]n(NO3)n (AgGlyGly), [Ag2(GlyAla)(NO3)2]n (AgGlyAla) and [Ag2(HGlyAsp)(NO3)]n (AgGlyAsp) were prepared, investigated and characterized by vibrational spectroscopy (mid-IR), elemental and thermogravimetric analysis and mass spectrometry. For AgGlyGly, X-ray crystallography was also performed. Their stability in biological testing media was verified by time-dependent NMR measurements. Their in vitro antimicrobial activity was evaluated against selected pathogenic microorganisms. Moreover, the influence of silver(I) dipeptide complexes on microbial film formation was described. Further, the cytotoxicity of the complexes against selected cancer cells (BLM, MDA-MB-231, HeLa, HCT116, MCF-7 and Jurkat) and fibroblasts (BJ-5ta) using a colorimetric MTS assay was tested, and the selectivity index (SI) was identified. The mechanism of action of Ag(I) dipeptide complexes was elucidated and discussed by the study in terms of their binding affinity toward the CT DNA, the ability to cleave the DNA and the ability to influence numbers of cells within each cell cycle phase. The new silver(I) dipeptide complexes are able to bind into DNA by noncovalent interaction, and the topoisomerase I inhibition study showed that the studied complexes inhibit its activity at a concentration of 15 µM.

Characterisation of factors contributing to the performance of nonwoven fibrous matrices as substrates for adenovirus vectored vaccine stabilisation.

Adenovirus vectors offer a platform technology for vaccine development. The value of the platform has been proven during the COVID-19 pandemic. Although good stability at 2-8 °C is an advantage of the platform, non-cold-chain distribution would have substantial advantages, in particular in low-income countries. We have previously reported a novel, potentially less expensive thermostabilisation approach using a combination of simple sugars and glass micro-fibrous matrix, achieving excellent recovery of adenovirus-vectored vaccines after storage at temperatures as high as 45 °C. This matrix is, however, prone to fragmentation and so not suitable for clinical translation. Here, we report an investigation of alternative fibrous matrices which might be suitable for clinical use. A number of commercially-available matrices permitted good protein recovery, quality of sugar glass and moisture content of the dried product but did not achieve the thermostabilisation performance of the original glass fibre matrix. We therefore further investigated physical and chemical characteristics of the glass fibre matrix and its components, finding that the polyvinyl alcohol present in the glass fibre matrix assists vaccine stability. This finding enabled us to identify a potentially biocompatible matrix with encouraging performance. We discuss remaining challenges for transfer of the technology into clinical use, including reliability of process performance.

Pyrolysis dynamics of two medical plastic wastes: Drivers, behaviors, evolved gases, reaction mechanisms, and pathways.

The public has started to increasingly scrutinize the proper disposal and treatment of rapidly growing medical wastes, in particular, given the COVID-19 pandemic, raised awareness, and the advances in the health sector. This research aimed to characterize pyrolysis drivers, behaviors, products, reaction mechanisms, and pathways via TG-FTIR and Py-GC/MS analyses as a function of the two medical plastic wastes of syringes (SY) and medical bottles (MB), conversion degree, degradation stage, and the four heating rates (5,10, 20, and 40 °C/min). SY and MB pyrolysis ranged from 394.4 to 501 and from 417.9 to 517 °C, respectively. The average activation energy was 246.5 and 268.51 kJ/mol for the SY and MB devolatilization, respectively. MB appeared to exhibit a better pyrolysis performance with a higher degradation rate and less residues. The most suitable reaction mechanisms belonged to a geometrical contraction model (R2) for the SY pyrolysis and to a nucleation growth model (A1.2) for the MB pyrolysis. The main evolved gases were C4-C24 alkenes and dienes for SY and C6-C41 alkanes and C8-C41 alkenes for MB. The pyrolysis dynamics and reaction pathways of the medical plastic wastes have important implications for waste stream reduction, pollution control, and reactor optimization.